Vertex Pharmaceuticals Inc
VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals NOL carryforwards — Foreign by Year
NOL carryforwards — Foreign ($M) ($M)
Vertex Pharmaceuticals NOL carryforwards — Foreign: $30.3M in FY2025, down 24.6% from a year earlier. That is the lowest of the 8 years on record here.
Latest, FY2025
30.3
Period ended Dec 31, 2025
Change on a year earlier
-24.6%
40.2 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Income Taxes).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | NOL carryforwards — Foreign ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.3 | -24.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 40.2 | -64.5% | Form 10-K (filed 2025-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 113 | -25.2% | Form 10-K (filed 2024-02-15) ↗ |
| FY2022 | Dec 31, 2022 | 151 | -48.2% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 293 | -43.9% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 522 | -41.8% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 897 | -4.8% | Form 10-K (filed 2020-02-13) ↗ |
| FY2018 | Dec 31, 2018 | 942 | – | Form 10-K (filed 2019-02-13) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals NOL carryforwards — Foreign ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nol-for
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.